Komori
StemRIM (4599) · RiskWorsened

Risk of retained earnings becoming negative again

First written in FY2020. 17 of 22 entries say "Worsened", first in FY2021-Q3. Latest entry: FY2026.

22entries
7years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseWorsenedFY2022-Q1 – FY2023-Q1WorsenedFY2023 – FY20262020: 12021: 420212022: 420222023: 420232024: 320242025: 220252026: 42026
Same theme, other companies
Carried-forward tax losses and the return of retained earnings to a deficitA theme 14 companies write about · 14 as a headwind · 0 as a tailwind

StemRIM moved to the "Worse" side of this theme in 2021, 2 years after the typical company in this theme (2019).

The whole theme swung hardest in 2021: 8 of 10 companies on the "Worse" side.

10 other companies' latest entry also says "Worsened".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026WorsenedAnnual report

    「As a result, share capital was ¥10 million, capital surplus was ¥9,786.385 million, and retained earnings were negative ¥5,634.751 million.」

    The deficit in retained earnings widened from negative ¥3,783.253 million at the end of the previous fiscal year to negative ¥5,634.751 million, further increasing the deficit in retained earnings carried forward.
  2. FY2026-H1WorsenedAnnual report

    「As a result, capital stock was ¥85.755 million, capital surplus was ¥9,710.630 million, and retained earnings were negative ¥4,711.891 million.」

    The deficit in retained earnings expanded from negative ¥3,783.253 million at the end of the previous fiscal year to negative ¥4,711.891 million, further increasing the renewed negative balance of retained earnings carried forward.
  3. FY2025WorsenedAnnual report

    「As a result, capital stock was ¥10.000 million, capital surplus was ¥9,634.875 million, and retained earnings were negative ¥3,783.253 million.」

    The deficit in retained earnings expanded from negative ¥1,853.816 million at the end of the previous fiscal year to negative ¥3,783.253 million, further increasing the renewed negative balance of retained earnings carried forward.
  4. FY2025-H1WorsenedAnnual report

    「As a result, capital stock was ¥116.400 million, capital surplus was ¥9,528.475 million, and retained earnings were negative ¥2,902.558 million.」

    The deficit in retained earnings expanded from negative ¥1,853.816 million at the end of the previous fiscal year to negative ¥2,902.558 million, and the renewed negative balance of retained earnings carried forward is progressing.
  5. FY2024WorsenedAnnual report

    「As a result, capital stock was ¥10.750 million, capital surplus was ¥9,422.825 million, and retained earnings were negative ¥1,853.816 million.」

    Retained earnings changed from positive ¥168.350 million at the end of the previous fiscal year to negative ¥1,853.816 million, worsening the renewed negative balance of retained earnings carried forward.
  6. FY2024-Q3WorsenedAnnual report

    「As a result, capital stock was ¥218.071 million, capital surplus was ¥9,214.003 million, and retained earnings were negative ¥1,350.649 million.」

    Retained earnings changed from positive ¥168.350 million at the end of the previous fiscal year to negative ¥1,350.649 million, further worsening the renewed negative balance of retained earnings carried forward.
  7. FY2024-Q2WorsenedAnnual report

    「As a result, capital stock was ¥207.622 million, capital surplus was ¥9,203.554 million, and retained earnings were negative ¥837.261 million.」

    The deficit in retained earnings changed from positive ¥168.350 million at the end of the previous fiscal year to negative ¥837.261 million, further worsening the renewed negative balance of retained earnings carried forward.
  8. FY2024-Q1WorsenedAnnual report

    「Retained earnings were negative ¥298.794 million.」

    Retained earnings changed from positive ¥168.350 million at the end of the previous fiscal year to negative ¥298.794 million, and the risk of retained earnings carried forward becoming negative again actually worsened.
  9. FY2023WorsenedAnnual report

    「As a result, capital stock was ¥15.752 million, capital surplus was ¥9,011.683 million, and retained earnings were ¥168.350 million.」

    Although retained earnings remained positive, they declined from ¥780.447 million at the end of the immediately preceding third quarter to ¥168.350 million, strengthening the risk of retained earnings carried forward becoming negative again compared with the previous disclosure.
  10. FY2023-Q3MitigatedAnnual report

    「As a result, at the end of the third quarter accounting period, capital stock was ¥159.571 million, capital surplus was ¥8,758.355 million, and retained earnings were ¥780.447 million.」

    As a result of the reduction in capital, deficit offsetting and the recognition of net income for the quarter, retained earnings changed from negative ¥2,182.994 million at the end of the previous fiscal year to positive ¥780.447 million, reducing the risk of retained earnings carried forward becoming negative again as of the end of the quarter.
  11. FY2023-Q2MitigatedAnnual report

    「The increased other capital surplus of ¥2,182.994 million was transferred to retained earnings carried forward, thereby eliminating the accumulated deficit of negative ¥2,182.994 million at the end of the previous fiscal year. In addition, capital stock and capital reserves each increased by ¥182.560 million as a result of the issuance of new shares as restricted stock compensation and the exercise of share acquisition rights. As a result, at the end of the second quarter accounting period, capital stock was ¥139.916 million, capital surplus was ¥8,738.699 million, and retained earnings were negative ¥1,016.664 million.」

    The accumulated deficit at the end of the previous fiscal year was eliminated through deficit offsetting, reducing the deficit in retained earnings. However, retained earnings remained negative ¥1,016.664 million at the end of the second quarter accounting period, so the risk has only been partially reduced.
  12. FY2023-Q1WorsenedAnnual report

    「Retained earnings were negative ¥2,696.495 million.」

    The deficit in retained earnings expanded from negative ¥2,182.994 million at the end of the previous fiscal year to negative ¥2,696.495 million, worsening the renewed negative balance of retained earnings carried forward.
  13. FY2022WorsenedAnnual report

    「As a result, capital stock was ¥76.315 million, capital surplus was ¥10,620.172 million, and retained earnings were negative ¥2,182.994 million.」

    The deficit in retained earnings expanded from positive ¥234.686 million at the end of the previous fiscal year and negative ¥1,735.242 million at the end of the previous quarter to negative ¥2,182.994 million, worsening the renewed negative balance of retained earnings carried forward.
  14. FY2022-Q3WorsenedAnnual report

    「As a result, capital stock was ¥66.876 million, capital surplus was ¥10,610.732 million, and retained earnings were negative ¥1,735.242 million.」

    The deficit in retained earnings expanded from negative ¥234.686 million at the end of the previous fiscal year and negative ¥1,242.556 million at the end of the previous quarter to negative ¥1,735.242 million, further increasing the renewed negative balance of retained earnings carried forward.
  15. FY2022-Q2WorsenedAnnual report

    「As a result, capital stock was ¥62.376 million, capital surplus was ¥10,606.232 million, and retained earnings were negative ¥1,242.556 million.」

    The deficit in retained earnings expanded from negative ¥234.686 million at the end of the previous fiscal year to negative ¥1,242.556 million, further increasing the renewed negative balance of retained earnings carried forward.
  16. FY2022-Q1WorsenedAnnual report

    「As a result, capital stock was ¥32.424 million, capital surplus was ¥10,500.407 million, and retained earnings were negative ¥234.686 million.」

    Retained earnings were negative ¥725.295 million at the end of the first quarter, widening from negative ¥234.686 million at the end of the previous fiscal year. The renewed negative balance of retained earnings carried forward has progressed further.
  17. FY2021RestatedAnnual report

    「As a result, capital stock was ¥32.424 million, capital surplus was ¥10,500.407 million, and retained earnings were negative ¥234.686 million.」

    Even after recording a net loss for the period, retained earnings remained negative ¥234.686 million, continuing to indicate the possibility of a delay before retained earnings carried forward become positive.
  18. FY2021-Q3WorsenedAnnual report

    「As a result, capital stock was ¥26.416 million, capital surplus was ¥10,494.400 million, and retained earnings were negative ¥946.651 million.」

    The deficit in retained earnings expanded from negative ¥428.781 million at the end of the previous quarter to negative ¥946.651 million, further worsening the renewed negative balance of retained earnings carried forward.
  19. FY2021-Q2MaterialisedAnnual report

    「As a result, capital stock was ¥24.799 million, capital surplus was ¥10,492.782 million, and retained earnings were negative ¥428.781 million.」

    Retained earnings, which were ¥347.761 million at the end of the previous fiscal year, became negative ¥428.781 million at the end of the quarter, meaning that retained earnings carried forward had in fact become negative again.
  20. FY2020First statedAnnual report

    「If the Company's business does not progress as planned and it is unable to generate earnings, retained earnings carried forward may become negative again.」

    Although the accumulated deficit was eliminated during the fiscal year, the Company disclosed the possibility that retained earnings carried forward could become negative again if development progress and earnings generation do not proceed as planned.
Moved together

"Risk of dilution from new share issuance and stock acquisition rights" moved the same way as this thread, in the same document, in 15 of its 22 moves.

15147322★123456
  1. ★This thread
  2. 1Risk of dilution from new share issuance and stock acquisition rights15×
  3. 2Negative operating cash flow and a lack of stable revenue sources14×
  4. 3Dependence on the partnership agreement with Shionogi & Co.,Ltd. and milestone revenue7×
  5. 4Applying for approval of an epidermolysis bullosa treatment following the Phase II trial3×
  6. 5Contributing to global health and well-being through therapies based on new concepts2×
  7. 6Expanding into a broad range of diseases through the regenerative-inducing medicine platform2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for StemRIM yet. It last moved in the Earnings of 2026-09-09: "Worsened".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.